BLFS
Price
$21.49
Change
-$0.54 (-2.45%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
810.87M
63 days until earnings call
MLSS
Price
$0.90
Change
-$0.01 (-1.10%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
47.46M
75 days until earnings call
Interact to see
Advertisement

BLFS vs MLSS

Header iconBLFS vs MLSS Comparison
Open Charts BLFS vs MLSSBanner chart's image
BioLife Solutions
Price$21.49
Change-$0.54 (-2.45%)
Volume$3.22K
Capitalization810.87M
Milestone Scientific
Price$0.90
Change-$0.01 (-1.10%)
Volume$2.7K
Capitalization47.46M
BLFS vs MLSS Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. MLSS commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and MLSS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (BLFS: $21.50 vs. MLSS: $0.90)
Brand notoriety: BLFS and MLSS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 67% vs. MLSS: 112%
Market capitalization -- BLFS: $810.87M vs. MLSS: $47.46M
BLFS [@Medical Specialties] is valued at $810.87M. MLSS’s [@Medical Specialties] market capitalization is $47.46M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileMLSS’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • MLSS’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 3 TA indicator(s) are bullish while MLSS’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 3 bullish, 6 bearish.
  • MLSS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, MLSS is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -3.67% price change this week, while MLSS (@Medical Specialties) price change was -7.18% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.32%. For the same industry, the average monthly price growth was +4.56%, and the average quarterly price growth was +1.00%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

MLSS is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Medical Specialties (+0.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than MLSS($47.5M). MLSS YTD gains are higher at: -5.250 vs. BLFS (-15.139). MLSS has higher annual earnings (EBITDA): -6.99M vs. BLFS (-45.24M). BLFS has more cash in the bank: 51.7M vs. MLSS (4.62M). MLSS has less debt than BLFS: MLSS (422K) vs BLFS (42.7M). BLFS has higher revenues than MLSS: BLFS (143M) vs MLSS (9.81M).
BLFSMLSSBLFS / MLSS
Capitalization811M47.5M1,707%
EBITDA-45.24M-6.99M647%
Gain YTD-15.139-5.250288%
P/E Ratio238.10N/A-
Revenue143M9.81M1,458%
Total Cash51.7M4.62M1,119%
Total Debt42.7M422K10,118%
FUNDAMENTALS RATINGS
BLFS vs MLSS: Fundamental Ratings
BLFS
MLSS
OUTLOOK RATING
1..100
356
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
9095
PRICE GROWTH RATING
1..100
6460
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLFS's Valuation (95) in the Medical Specialties industry is in the same range as MLSS (95). This means that BLFS’s stock grew similarly to MLSS’s over the last 12 months.

BLFS's Profit vs Risk Rating (82) in the Medical Specialties industry is in the same range as MLSS (100). This means that BLFS’s stock grew similarly to MLSS’s over the last 12 months.

BLFS's SMR Rating (90) in the Medical Specialties industry is in the same range as MLSS (95). This means that BLFS’s stock grew similarly to MLSS’s over the last 12 months.

MLSS's Price Growth Rating (60) in the Medical Specialties industry is in the same range as BLFS (64). This means that MLSS’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for MLSS (100). This means that BLFS’s stock grew significantly faster than MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSMLSS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVPT19.240.28
+1.48%
AvePoint
AGI27.100.19
+0.71%
Alamos Gold
NVEC71.81-0.07
-0.10%
NVE Corp
USIO1.39-0.01
-0.71%
Usio
MNST63.16-0.83
-1.30%
Monster Beverage Corp

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+3.04%
RGEN - BLFS
55%
Loosely correlated
+1.73%
RVTY - BLFS
48%
Loosely correlated
+1.51%
DHR - BLFS
48%
Loosely correlated
+0.53%
TWST - BLFS
47%
Loosely correlated
-1.42%
AZTA - BLFS
46%
Loosely correlated
+7.47%
More

MLSS and

Correlation & Price change

A.I.dvisor tells us that MLSS and BLFS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MLSS and BLFS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
-1.13%
BLFS - MLSS
27%
Poorly correlated
+3.04%
ESTA - MLSS
26%
Poorly correlated
+1.31%
SRDX - MLSS
26%
Poorly correlated
+1.66%
GKOS - MLSS
25%
Poorly correlated
-3.74%
VTAK - MLSS
25%
Poorly correlated
+2.55%
More